Ohio Bioscience News

Click a news item to be directed to the full story. Send your news to bioohio@bioohio.com.

Found 6552 Results

AtriCure earns groundbreaking FDA approval

West Chester-based medical device company AtriCure (Nasdaq: ATRC) announced Friday that the FDA has approved their Synergy Ablation System for the treatment of atrial fibrillation (AF). Specifically, the Synergy Ablation System has been approved for the treatment of patients with persistent and long-standing persistent AF during open-heart procedures. This is the first time a surgical ablation […]

December 19, 2011

Austen BioInnovation Institute to partner with FDA on medical device safety initiatives

Today the Austen BioInnovation Institute in Akron (ABIA) and the U.S. Food and Drug Administration (FDA) executed a Memorandum of Understanding that will allow the FDA to draw upon ABIA resources to support the FDA’s safety review of biomaterials used in medical devices. Working with the FDA, ABIA will identify and convene a steering committee […]

December 15, 2011

ChanTest inks agreement with Roche to perform cardiac safety testing

Cleveland’s ChanTest Corporation, a leading ion channel screening provider, will soon be working with Roche’s Diagnostic Division to perform cardiac safety testing of potential drug compounds. ChanTest will use Roche’s xCELLigence RTCA Cardio Instrument and Cellular Dynamics International’s iCell Cardiomyocytes to measure pharmacological responses to a variety of compounds that have been selected based on […]

December 13, 2011

Wright-Patt scientist becomes first U.S. citizen honored with British award

Nevermind this occurred a couple months ago, it’s a cool Ohio story that needs to shared. In September, Lt. Col. Laura Barnes of the Air Force Research Laboratory’s 711th Human Performance Wing received the Special Commendation Coin from the United Kingdom’s Defence Science and Technology Laboratory. The award is one of the highest honors bestowed […]

December 8, 2011

R&D services and higher education converge in Toledo

Last year, the Center for Drug Design and Development (CD3) at the University of Toledo received a call from B&G Partners, a biotech startup in Illinois. The company was looking for help developing an anti-cancer agent to treat triple negative breast cancer, for which there is no current therapy. B&G Partners wanted one source for synthetic medicinal […]

December 6, 2011

Ohio Third Frontier launches Technology Validation and Start-up Fund

Last week, the Ohio Third Frontier released the RFP for a brand new program designed to help start-up companies that are commercializing technologies out of Ohio’s higher education assets. The Ohio Third Frontier Technology Validation and Start-up Fund has been designed to: (1) Support protected technologies developed at Ohio institutions of higher education that need […]

December 2, 2011

Columbus firm plays key role in world’s second successful synthetic trachea transplant

Nanofiber Solutions designed and built the nanofiber tracheal scaffold upon which a patient’s own stem cells were grown before transplantation on November 17 at Karolinska University Hospital in Stockholm by Dr. Paolo Macchiarini. The patient, Christopher Lyles, is a 30-year-old from Baltimore, Maryland, and is making a good recovery. This transplant follows the world’s first […]

November 29, 2011

Neuros Medical gets FDA OK to launch pilot study

Medical device company Neuros Medical has received an Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration, paving the way for a pilot clinical trial to evaluate the company’s patented high frequency Electrical Nerve Block technology for use in acute treatment of pain in the residual limb of amputees. The IDE approval follows the Cleveland […]

November 28, 2011

NEOMED seeking Ohio partners to multiply impact

A recent article in the Akron Beacon-Journal describes Northeast Ohio Medical University’s desire to establish more partnerships in the private and public sectors. Formerly NEOUCOM, NEOMED is looking “for ways to join with regional partners for educational, research and job-creation initiatives.” The “new synergy” for higher education requires colleges to work with government entities, businesses and […]

November 25, 2011

BioOhio voices concern over medical device excise tax

Last week, Columbus Business First and The Plain Dealer published an op-ed by BioOhio President & CEO Tony Dennis in which he expressed concerns on how a part of the health care reform legislation could dampen biomedical innovation and manufacturing in Ohio and throughout the country. Here it is in its entirety: Many of our […]

November 22, 2011